Cassava Sciences Inc (SAVA)

3.02 +0.08 (+2.72%) USD  |  NASDAQ  |  Jan 07, 16:00
3.02 0.00 (0.00%) After-Hours: 16:35
More

Cassava Sciences Research and Development Expense (Annual): 89.42M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for SAVA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
BridgeBio Pharma Inc 455.71M
Alnylam Pharmaceuticals Inc 1.004B
Altimmune Inc 65.80M
PTC Therapeutics Inc 666.56M
Scholar Rock Holding Corp 121.90M